Custom Gene-Targeting drug offers hope for one child with fatal brain disorder

This study tests a custom-made drug for one child with a rare, severe brain disease called CONDBA, caused by a specific gene mutation. The drug aims to slow or stop brain damage by targeting the faulty gene. Researchers will track changes in movement, coordination, and quality of life over two years, while closely monitoring safety.